<DOC>
	<DOCNO>NCT00001168</DOCNO>
	<brief_summary>Lipoproteins particle carry fat cholesterol triglyceride blood stream . These particle involve cause blood vessel disease lead condition like harden artery ( atherosclerosis ) heart attack ( myocardial infarction ) . This study design look closely factor affect lipoprotein . Researchers plan study patient normal volunteer measure lipoprotein level blood . Patients volunteer place balance diet study . In addition , researcher plan measure level various hormone enzymes blood . Patients volunteer participate study may ask undergo specific test order collect information lipoprotein metabolism . This study may provide direct benefit patient volunteer participate . However , information gather study may help researcher develop good skill technique diagnose treat patient diseases lipoprotein metabolism .</brief_summary>
	<brief_title>Evaluation Lipoproteins</brief_title>
	<detailed_description>The lipoprotein transport system vital delivery hydrophobic fat carry aqueous environment blood . The lipoprotein particles comprise system polydisperse contain triglyceride , free esterify cholesterol , phospholipids protein . Inborn error lipoprotein transport system lead alteration steady state concentration various lipoprotein metabolism particle . These inborn error lead hyperlipoproteinemia hypolipoproteinemia . Profound change ambient lipoprotein concentration variety clinical manifestation . The present study protocol design permit full evaluation lipid , lipoprotein , apolipoproteins , patient potential genetic defect process . The protocol also permit train student , staff clinician , physician assistant , nurse practitioner , dieticians post-doctoral fellow evaluation treatment patient dyslipidemias . The study population include patient refer Lipid Service private care provider , academic institution , NHLBI Lipid website , follow potential lipid abnormality clinical stigma associate dyslipoproteinemias : ) increase plasma level cholesterol , triglyceride , HDL-cholesterol LDL-cholesterol b ) decrease plasma concentration cholesterol HDL-cholesterol c ) postprandial hyperlipidemia ) eruptive xanthoma , xanthelasma , tuberous tendinous xanthoma , corneal opacity .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hyperlipoproteinemias</mesh_term>
	<mesh_term>Hypolipoproteinemias</mesh_term>
	<criteria>INCLUSION CRITERIA : Plasma cholesterol level great 200 mg/dl less 120 mg/dl include patient diagnose familial hypercholesterolemia , familial combine hyperlipidemia , sitosterolemia , cholesteryl ester storage disease , Erdheim chester disease , lipoprotein lipase , hepatic lipase apoCII deficiency , dysbetalipoproteinemia . Plasma LDLC level great 130 mg/dl less 70 mg/dl include patient diagnose familial hypercholesterolemia , familial combine hyperlipidemia , lipoprotein lipase , hepatic lipase , apoCII deficiency , sitosterolemia , dysbetalipoproteinemia , abetalipoproteinemia hypobetalipoproteinemia . Plasma HDLC level great 70 mg/dl less 25 mg/dl include patient deficiency cholesteryl ester transfer protein , lecithin cholesterol acyltransferase , phospholipid transfer protein , lipoprotein lipase , hepatic lipase , apoCII , Tangier disease . Plasma triglyceride level great 150 mg/dl include patient deficiency lipoprotein lipase , hepatic lipase apoCII , dysbetalipoproteinemia , Type IV Type V hyperlipidemia . EXCLUSION CRITERIA : Inability provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 23, 2017</verification_date>
	<keyword>Dyslipoproteinemia</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Hypertriglyceridemia</keyword>
	<keyword>hypoalphalipoproteinemia</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Type III Hyperlipoproteinemia</keyword>
	<keyword>Plasma Lipoproteins</keyword>
</DOC>